Accurate Wealth Management LLC Purchases New Position in iShares U.S. Pharmaceuticals ETF $IHE

Accurate Wealth Management LLC purchased a new position in shares of iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) during the 4th quarter, Holdings Channel reports. The institutional investor purchased 75,126 shares of the company’s stock, valued at approximately $6,372,000. iShares U.S. Pharmaceuticals ETF comprises approximately 0.8% of Accurate Wealth Management LLC’s investment portfolio, making the stock its 19th largest holding.

Other institutional investors and hedge funds have also made changes to their positions in the company. Mather Group LLC. acquired a new stake in shares of iShares U.S. Pharmaceuticals ETF during the third quarter valued at about $38,000. Ameriflex Group Inc. grew its position in shares of iShares U.S. Pharmaceuticals ETF by 100.0% during the third quarter. Ameriflex Group Inc. now owns 582 shares of the company’s stock worth $42,000 after buying an additional 291 shares in the last quarter. National Bank of Canada FI increased its stake in shares of iShares U.S. Pharmaceuticals ETF by 42.7% in the third quarter. National Bank of Canada FI now owns 585 shares of the company’s stock worth $42,000 after buying an additional 175 shares during the last quarter. CX Institutional boosted its stake in iShares U.S. Pharmaceuticals ETF by 2,665.5% during the 3rd quarter. CX Institutional now owns 802 shares of the company’s stock valued at $58,000 after acquiring an additional 773 shares during the last quarter. Finally, Rothschild Investment LLC grew its holdings in iShares U.S. Pharmaceuticals ETF by 116.9% during the 3rd quarter. Rothschild Investment LLC now owns 846 shares of the company’s stock worth $61,000 after acquiring an additional 456 shares in the last quarter.

iShares U.S. Pharmaceuticals ETF Stock Performance

NYSEARCA:IHE opened at $83.79 on Friday. The stock has a 50-day simple moving average of $88.09 and a 200 day simple moving average of $82.22. iShares U.S. Pharmaceuticals ETF has a one year low of $58.97 and a one year high of $92.29. The company has a market capitalization of $938.45 million, a price-to-earnings ratio of 17.75 and a beta of 0.54.

iShares U.S. Pharmaceuticals ETF Company Profile

iShares U.S. Pharmaceuticals ETF, formerly iShares Dow Jones U.S. Pharmaceuticals Index Fund (the Fund), is an exchange traded fund. The Fund seeks investment results that correspond generally to the price and yield performance of the Dow Jones U.S. Select Pharmaceuticals Index (the Index). The Index measures the performance of the pharmaceuticals sector of the United States equity market, and includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines, but excludes producers of vitamins.